Corresponding author: Jaime Prat, Department of Pathology, Building C, Floor -2, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Sant Quintí, 87-89, 08041 Barcelona, Spain; e-mail: [email protected]. * Members of the FIGO Committee on Gynecologic Oncology: H. Belhadj (Switzerland), J. Berek (USA), A. Bermudez (Argentina), N. Bhatla (India), J. Cain (USA), L. Denny (Chair; South Africa), K. Fujiwara (Japan), N. Hacker (Australia), E. Åvall-Lundqvist (Sweden), D. Mutch (USA), F. Odicino (Italy), S. Pecorelli (Italy), J. Prat (Spain), M. Quinn (Co-chair; Australia), M.A.-F. Seoud (Lebanon), S.K. Shrivastava (India). This article is an abridged version of the staging classification published in the International Journal of Gynecology and Obstetrics in January 2014. Please cite the original article as: Prat J; FIGO Committee on Gynecologic Oncology. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynecol Obstet 2014;124(1):1−5.
No takes yet. Share an insight, caveat, or question.
Jaime Prat (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: